Concepts (123)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Spinal Cord Injuries | 6 | 2023 | 21 | 2.320 |
Why?
|
| Toll-Like Receptor 9 | 3 | 2014 | 6 | 0.990 |
Why?
|
| Oligodeoxyribonucleotides | 2 | 2014 | 5 | 0.890 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2021 | 25 | 0.740 |
Why?
|
| Hydrogen Peroxide | 1 | 2020 | 44 | 0.690 |
Why?
|
| Spinal Cord | 3 | 2023 | 72 | 0.530 |
Why?
|
| Urinary Retention | 1 | 2014 | 9 | 0.460 |
Why?
|
| Urinary Bladder | 1 | 2014 | 20 | 0.460 |
Why?
|
| Animals | 8 | 2023 | 3551 | 0.450 |
Why?
|
| Rats | 4 | 2023 | 634 | 0.440 |
Why?
|
| White Matter | 1 | 2014 | 126 | 0.410 |
Why?
|
| Hyperalgesia | 1 | 2013 | 39 | 0.400 |
Why?
|
| Urinary Bladder Diseases | 1 | 2010 | 7 | 0.350 |
Why?
|
| NAD | 1 | 2023 | 2 | 0.220 |
Why?
|
| Dysbiosis | 1 | 2023 | 55 | 0.200 |
Why?
|
| Schwann Cells | 1 | 2021 | 2 | 0.190 |
Why?
|
| Cell Hypoxia | 1 | 2021 | 11 | 0.190 |
Why?
|
| Nerve Regeneration | 1 | 2021 | 14 | 0.190 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2021 | 10 | 0.190 |
Why?
|
| Cell Death | 1 | 2021 | 46 | 0.190 |
Why?
|
| Axons | 1 | 2021 | 28 | 0.180 |
Why?
|
| Mice | 3 | 2014 | 1380 | 0.180 |
Why?
|
| Oxidative Stress | 1 | 2021 | 106 | 0.180 |
Why?
|
| Cellular Reprogramming | 1 | 2020 | 2 | 0.170 |
Why?
|
| Hypoxia | 1 | 2020 | 34 | 0.170 |
Why?
|
| Pluripotent Stem Cells | 1 | 2020 | 5 | 0.170 |
Why?
|
| Cell Survival | 1 | 2020 | 114 | 0.170 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2020 | 18 | 0.170 |
Why?
|
| Small Molecule Libraries | 1 | 2019 | 2 | 0.160 |
Why?
|
| Receptors, Steroid | 1 | 2019 | 2 | 0.160 |
Why?
|
| Spondylosis | 1 | 2019 | 18 | 0.160 |
Why?
|
| Lordosis | 1 | 2019 | 24 | 0.160 |
Why?
|
| Peptides | 1 | 2019 | 97 | 0.150 |
Why?
|
| Female | 8 | 2019 | 14520 | 0.140 |
Why?
|
| Diskectomy | 1 | 2019 | 139 | 0.140 |
Why?
|
| Mice, Inbred C57BL | 3 | 2013 | 420 | 0.140 |
Why?
|
| Cervical Vertebrae | 1 | 2019 | 247 | 0.130 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2018 | 186 | 0.130 |
Why?
|
| Orthopedic Procedures | 1 | 2018 | 300 | 0.120 |
Why?
|
| Lumbar Vertebrae | 1 | 2018 | 296 | 0.110 |
Why?
|
| Immunomodulation | 1 | 2013 | 7 | 0.110 |
Why?
|
| Sensation | 1 | 2013 | 11 | 0.110 |
Why?
|
| Immunophenotyping | 1 | 2013 | 29 | 0.110 |
Why?
|
| Behavior, Animal | 1 | 2013 | 45 | 0.110 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2013 | 33 | 0.100 |
Why?
|
| Flow Cytometry | 1 | 2013 | 114 | 0.100 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 134 | 0.100 |
Why?
|
| Postoperative Complications | 1 | 2018 | 825 | 0.100 |
Why?
|
| Immunohistochemistry | 1 | 2013 | 349 | 0.100 |
Why?
|
| Mothers | 1 | 2013 | 162 | 0.090 |
Why?
|
| Inflammation | 1 | 2013 | 264 | 0.090 |
Why?
|
| Nerve Crush | 1 | 2010 | 1 | 0.090 |
Why?
|
| Urination | 1 | 2010 | 3 | 0.090 |
Why?
|
| Pons | 1 | 2010 | 5 | 0.090 |
Why?
|
| Contusions | 1 | 2010 | 3 | 0.090 |
Why?
|
| Hindlimb | 1 | 2010 | 17 | 0.090 |
Why?
|
| Motor Activity | 1 | 2013 | 311 | 0.090 |
Why?
|
| Locomotion | 1 | 2010 | 23 | 0.090 |
Why?
|
| Organ Size | 1 | 2010 | 95 | 0.090 |
Why?
|
| Neural Pathways | 1 | 2010 | 65 | 0.090 |
Why?
|
| Disease Models, Animal | 1 | 2013 | 600 | 0.080 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2010 | 328 | 0.080 |
Why?
|
| Recovery of Function | 1 | 2010 | 285 | 0.080 |
Why?
|
| Memory | 2 | 2013 | 292 | 0.070 |
Why?
|
| Hippocampus | 2 | 2013 | 268 | 0.070 |
Why?
|
| Humans | 7 | 2023 | 26260 | 0.060 |
Why?
|
| Epilepsy, Temporal Lobe | 1 | 2004 | 22 | 0.060 |
Why?
|
| Verbal Learning | 1 | 2004 | 33 | 0.060 |
Why?
|
| Niacinamide | 1 | 2023 | 6 | 0.050 |
Why?
|
| Rats, Long-Evans | 1 | 2023 | 11 | 0.050 |
Why?
|
| Pyridinium Compounds | 1 | 2023 | 5 | 0.050 |
Why?
|
| Paralysis | 1 | 2023 | 12 | 0.050 |
Why?
|
| Central Nervous System | 1 | 2023 | 55 | 0.050 |
Why?
|
| Male | 5 | 2019 | 14168 | 0.050 |
Why?
|
| Brain | 1 | 2010 | 1603 | 0.050 |
Why?
|
| Genomic Instability | 1 | 2020 | 7 | 0.040 |
Why?
|
| Regenerative Medicine | 1 | 2020 | 4 | 0.040 |
Why?
|
| Receptors, Androgen | 1 | 2019 | 6 | 0.040 |
Why?
|
| Receptors, Progesterone | 1 | 2019 | 23 | 0.040 |
Why?
|
| Cell Differentiation | 1 | 2020 | 129 | 0.040 |
Why?
|
| Biocompatible Materials | 1 | 2020 | 94 | 0.040 |
Why?
|
| Binding Sites | 1 | 2019 | 62 | 0.040 |
Why?
|
| Protein Conformation | 1 | 2019 | 60 | 0.040 |
Why?
|
| Models, Molecular | 1 | 2019 | 62 | 0.040 |
Why?
|
| Neck | 1 | 2019 | 24 | 0.040 |
Why?
|
| Receptors, Estrogen | 1 | 2019 | 54 | 0.040 |
Why?
|
| Protein Binding | 1 | 2019 | 118 | 0.040 |
Why?
|
| Bone Plates | 1 | 2019 | 46 | 0.040 |
Why?
|
| Middle Aged | 2 | 2019 | 8541 | 0.030 |
Why?
|
| Aged | 2 | 2019 | 8595 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2019 | 1665 | 0.030 |
Why?
|
| Zymosan | 1 | 2013 | 5 | 0.030 |
Why?
|
| Injections, Intraperitoneal | 1 | 2013 | 5 | 0.030 |
Why?
|
| Myelin-Oligodendrocyte Glycoprotein | 1 | 2013 | 5 | 0.030 |
Why?
|
| Habituation, Psychophysiologic | 1 | 2013 | 1 | 0.030 |
Why?
|
| Poly I-C | 1 | 2013 | 6 | 0.030 |
Why?
|
| Reflex, Startle | 1 | 2013 | 4 | 0.030 |
Why?
|
| Illness Behavior | 1 | 2013 | 3 | 0.030 |
Why?
|
| Maze Learning | 1 | 2013 | 16 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2013 | 101 | 0.030 |
Why?
|
| Th17 Cells | 1 | 2013 | 25 | 0.030 |
Why?
|
| Acoustic Stimulation | 1 | 2013 | 55 | 0.030 |
Why?
|
| Peptide Fragments | 1 | 2013 | 71 | 0.030 |
Why?
|
| Hand Strength | 1 | 2013 | 57 | 0.030 |
Why?
|
| Spinal Fusion | 1 | 2019 | 376 | 0.030 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2013 | 55 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2013 | 298 | 0.020 |
Why?
|
| Movement Disorders | 1 | 2013 | 88 | 0.020 |
Why?
|
| Pregnancy | 1 | 2013 | 312 | 0.020 |
Why?
|
| Phenotype | 1 | 2013 | 305 | 0.020 |
Why?
|
| Anxiety | 1 | 2013 | 149 | 0.020 |
Why?
|
| Postural Balance | 1 | 2013 | 116 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2013 | 505 | 0.020 |
Why?
|
| Adult | 2 | 2019 | 7516 | 0.020 |
Why?
|
| Pain | 1 | 2013 | 380 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2018 | 3283 | 0.020 |
Why?
|
| Visual Perception | 1 | 2004 | 30 | 0.010 |
Why?
|
| Functional Laterality | 1 | 2004 | 59 | 0.010 |
Why?
|
| Anticonvulsants | 1 | 2004 | 54 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2004 | 422 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 2004 | 1192 | 0.010 |
Why?
|
| Quality of Life | 1 | 2004 | 606 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2004 | 1069 | 0.010 |
Why?
|